HomePAR • ASX
add
Paradigm Biopharmaceuticals Ltd
Nakaraang pagsara
$0.25
Sakop ng araw
$0.25 - $0.27
Sakop ng taon
$0.24 - $0.48
Market cap
114.21M AUD
Average na Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 12.58K | 50.60% |
Gastos sa pagpapatakbo | 10.92M | 244.32% |
Net na kita | -11.62M | -292.37% |
Net profit margin | -92.42K | -160.54% |
Kita sa bawat share | — | — |
EBITDA | -10.88M | -246.66% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.74M | -40.53% |
Kabuuang asset | 23.15M | -34.52% |
Kabuuang sagutin | 17.16M | 1,217.97% |
Kabuuang equity | 6.00M | — |
Natitirang share | 428.52M | — |
Presyo para makapag-book | 25.00 | — |
Return on assets | -117.85% | — |
Return on capital | -177.46% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -11.62M | -292.37% |
Cash mula sa mga operasyon | -9.82M | -139.05% |
Cash mula sa pag-invest | -283.60K | -1,327.71% |
Cash mula sa financing | 9.15M | 21.02% |
Net change in cash | -1.08M | -130.97% |
Malayang cash flow | -7.34M | -283.05% |
Tungkol
Itinatag
2014
Website
